Alzheimer Disease

Missed trial procedures, made-up emails, and an unsuccessful endpoint make a mess Alzheimer's agitation readout from BioXCel | Pharmtales

Missed trial procedures, made-up emails, and an unsuccessful endpoint make a mess Alzheimer’s agitation readout from BioXCel

SG Tylor

Source – BioXcel Therapeutics On June 29, 2023, a potential breakthrough in the treatment of agitation episodes in Alzheimer’s disease ...

CMS unveils details of its registry strategy for drugs targeting Alzheimer's disease

CMS unveils details of its registry strategy for drugs targeting Alzheimer’s disease

SG Tylor

Centers for Medicare and Medicaid Services (CMS) reveals additional details regarding its controversial plan to mandate participation in a patient ...